Characteristics of Pan-Cancer Patients With Ultrahigh Tumor Mutation Burden

BACKGROUND: Tumor mutation burden has been proven to be a good predictor for the efficacy of immunotherapy, especially in patients with hypermutation. However, most research focused on the analysis of hypermutation in individual tumors, and there is a lack of integrated research on the hypermutation...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Hong, Ji, Jun, Shi, Min, Shi, Yan, Liu, Jing, Wu, Junwei, Yang, Chen, Xi, Wenqi, Li, Qingyuan, Zhu, Wei, Li, Jingjie, Gong, Xiaoli, Zhang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100597/
https://www.ncbi.nlm.nih.gov/pubmed/33968789
http://dx.doi.org/10.3389/fonc.2021.682017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100597/
https://www.ncbi.nlm.nih.gov/pubmed/33968789
http://dx.doi.org/10.3389/fonc.2021.682017

Ejemplares similares